The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature
Submitted: 11 May 2017
Accepted: 5 December 2017
Published: 6 July 2018
Accepted: 5 December 2017
Abstract Views: 2323
PDF: 1217
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.